Effects of d- and l-limonene on the pregnant rat myometrium in vitro by Hajagos-Tóth, Judit et al.
431
www.cmj.hr
Aim To study the effects of d- and l-limonene on preg-
nant rat myometrial contractility in vitro, and investigate 
how these effects are modified by other agents. D- and l-
limonene (10−13-10−8 M) caused myometrial contraction in 
a dose-dependent manner.
Methods Contractions of uterine rings from 22-day-preg-
nant rats were measured in an organ bath in the presence 
of d- or l-limonene (10−13-10−8 M) and nifedipine (10−8 M), 
tetraethyl-ammonium (10−3 M), theophylline (10−5 M), or 
paxilline (10−5 M). Uterine cyclic adenosine monophos-
phate (cAMP) level was detected by enzyme immuno-
assay. Oxidative damage was induced by methylglyoxal 
(3 × 10−2 M) and the alteration was measured via noradren-
aline (1 × 10−9 to 3 × 10−5 M) -induced contractions.
Results Pre-treatment with nifedipine (10−8 M), tetraeth-
ylammonium (10−3 M), and theophylline (10−5 M) attenu-
ated the contracting effect of d- and l-limonene, while in 
the presence of paxilline (10−5 M) d- and l-limonene were 
ineffective. The two enantiomers decreased the myome-
trial cAMP level, but after paxilline pretreatment the cAMP 
level was not altered compared with the control value. Ad-
ditionally, l-limonene (10−6 M) diminished consequences of 
oxidative damage caused by methylglyoxal (3 × 10−2 M) on 
contractility, whereas d-limonene was ineffective.
Conclusion Our findings suggest that l-limonene has an 
antioxidant effect and that both d-and l-limonene cause 
myometrial contraction through activation of the A2A re-
ceptor and opening of the voltage-gated Ca2+ channel. 
It is possible that limonene-containing products increase 
the pregnant uterus contractility and their use should be 
avoided during pregnancy.
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Over the past few decades there has been a significant in-
crease in the usage of self-prescribed complementary and 
alternative medication during pregnancy, such as herb-
al remedies, relaxation therapies, and aromatherapy (1-3). 
These products are mistakenly perceived to be safe and are 
mostly used in treating anxiety, insomnia, fatigue, back pain, 
constipation, and heartburn (1-5). For example, almond oil 
is widely believed to be a good nutrient for the developing 
fetus, however it has been proven to induce preterm birth 
(3). Since there is a lack of evidence on the safety of herbal 
medications and essential oils use during pregnancy, more 
information on this issue should be obtained.
Limonene is a chiral molecule classified as a monoterpene 
and occurring as two optical enantiomers: d-limonene or 
[R(+)-enantiomer] and l-limonene or [S(-)-enantiomer] (6). 
It is mostly present in plants in its d-enantiomeric form or, 
to a lesser extent, as a racemic mixture (7). Limonene is a 
major component of several plant essential oils, including 
orange, lemon, mandarine, lime, and grapefruit. Because 
of its pleasant lemon-like sweet fragrance it is widely used 
as an additive to perfumes, soaps, foods, chewing gums, 
and beverages (8). D-limonene is also used therapeuti-
cally to dissolve cholesterol-containing bilestones (9) and 
relieve heartburn (10). It is rapidly and almost completely 
absorbed from the gastrointestinal tract (11). D-limonene 
has low toxicity and does not have any mutagenic, carci-
nogenic, or nephrotoxic risk to humans (12). Furthermore, 
it has a chemotherapeutic (13), anti-inflammatory (14), 
anxiolytic (15), antinociceptive (16), and potent antioxidant 
effects (17). It modifies the myometrial relaxing effect of 
terbutaline and decreases its cervical resistance-enhancing 
effect, however little is known about its mechanism of ac-
tion (18). Some monoterpenoids have known mechanisms 
of action: eg, camphor and borneol are non-competitive 
inhibitors of neural acetylcholine receptors (19) and thy-
mol inhibits Ca2+ and K+ channels in human ventricular car-
diomyocytes (20). Monoterpenes induce vascular smooth 
muscle relaxation in rat mesenteric arteries through activa-
tion of large conductance Ca2+-activated potassium (BKCa) 
channels and inhibition of the L-type Ca2+ channels (21), 
and relaxation in isolated rabbit ileum through NO path-
way and inhibition of L-type Ca2+ channels (22). Eucalyp-
tol induces relaxation in rat and guinea-pig airway smooth 
muscle through non-specific mechanisms (23).
Since no experiments have been carried out to investigate 
the effect of limonene on myometrial smooth muscle, our 
primary aim was to study the effects of limonene on 
pregnant Sprague-Dawley rat myometrium on the 
last day of pregnancy in vitro. Since intracellular Ca2+ plays 
an important role in the mechanism of action of monoter-
penoids (21-23), our second aim was to investigate how the 
myometrial effect of limonene can be modified in the pres-
ence of the L-type Ca2+ channel blocker nifedipine, selec-
tive BKCa channel blocker paxilline, non-selective potassium 
channel blocker tetraethyl-ammonium (TEA), and non-se-
lective adenosine receptor antagonist theophylline.
MATeRiAlS And MeTHodS
All experiments were carried out with the approval of the 
Hungarian Ethics Committee for Animal Research (regis-
tration number: IV/198/2013). The animals were treated in 
accordance with the European Communities Council Di-
rectives (86/609/ECC) and the Hungarian Act for the Pro-
tection of Animals in Research (XXVIII. tv. 32.§).
Mating of the animals
In each experiment, mature female (180-200 g) (n = 8) and 
male (240-260 g) (n = 3) Sprague-Dawley rats were mated 
in a mating cage. The cage has a time-controlled movable 
metal door separating male from female animals. Since 
rats are usually active at night, the separating door was 
opened before dawn. Within 4-5 hours after the possible 
mating, vaginal smears were taken and a sperm search was 
performed under a microscope at a 1200 × magnification. 
Female rats with positive smear and those in whom the 
smear was not taken due to vaginal sperm plug were re-
garded as first-day pregnant animals.
Uterus preparation
Uteri were removed from rats (n = 8 in each experiment) 
(250-350 g) on the 22nd day of pregnancy. 5 mm-long 
muscle rings were sliced from uterine horns and mounted 
vertically in an organ bath containing 10 mL de Jongh so-
lution (composition: 137 mM NaCl, 3 mM KCl, 1 mM Ca-
Cl2, 1 mM MgCl2, 12 mM NaHCO3, 4 mM NaH2PO4, 6 mM 
glucose, pH = 7.4). The organ bath was maintained at 37°C, 
and carbogen (95% O2 + 5% CO2) was bubbled through 
it. After mounting, the rings were equilibrated for about 
1 h before the experiments were conducted, with a solu-
tion change every 15 min. The tension of myometrial rings 
was set at about 1.25 g. The tension of myometrial rings 
was measured with a gauge transducer (SG-02; Experime-
tria Ltd, Budapest, Hungary) and recorded with a SPEL Ad-
vanced ISOSYS Data Acquisition System (Experimetria Ltd, 
Budapest, Hungary).
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d- and l-limonene contractility studies
In each experiment, cumulative dose-response curves 
were constructed in the presence of d- and l-limonene 
(10−13-10−8 M) (Sigma-Aldrich, Budapest, Hungary). After 
each concentration of limonene was added, recording was 
performed for 300 s.
Combination of d- and l-limonene with nifedipine, 
paxilline, TeA, and theophylline
After pre-treatment with nifedipine (5 minutes) (10−8 M), 
paxilline (10 minutes) (10−5 M), TEA (10 minutes) (10−3 M), 
and theophylline (10 minutes) (10−5 M) (all from Sigma-Al-
drich), cumulative dose-response curves were constructed 
in the presence of D- and l-limonene (10−13-10−8 M). The 
incubation period was chosen based on the data from our 
previous studies (24,25).
Methylglyoxal (MGo) studies
N-acetyl-cysteine (NAC) has already been demonstrated to 
reduce the inhibitory effect of MGO on rat mesenteric ar-
tery in vitro (26). For comparison, we examined the effect 
of NAC (10−7 M) and another well-known antioxidant, to-
copherol (10−7 M) on MGO-treated myometrium. After 30 
minutes of pre-treatment with MGO (3 × 10−2 M), l- and d-
limonene (10−6 M), tocopherol (10−7 M), and NAC (10−7 M) 
(Sigma-Aldrich), contractions were elicited with noradren-
aline (NA) (1 × 10−9 to 3 × 10−5 M) and cumulative dose-re-
sponse curves were constructed in each experiment in the 
presence of propranolol (10−5 M) (Sigma-Aldrich) in order 
to avoid β-adrenergic action. After each concentration of 
NA was added, recording was performed for 300 s.
Measurement of uterine cyclic adenosine 
monophosphate (cAMP) accumulation
Uterine cAMP accumulation was measured with a commer-
cial cAMP Enzyme Immunoassay Kit (Sigma-Aldrich, Buda-
pest, Hungary). Uterine tissue samples were incubated in 
an organ bath (10 mL) with isobuthylmethylxantine (IBMX) 
(10−3 M) and paxilline (10−5 M) for 10 minutes, after which 
d- and l-limonene (10−13, 10−9 M) were added for another 3 
minutes. At the end of limonene incubation, forskolin (10−5 
M) was added for another 10 min. After stimulation, the 
samples were immediately frozen in liquid nitrogen and 
stored until the cAMP extraction (27). Frozen tissue sam-
ples were then ground, weighed, homogenized in 10 vol-
umes of ice-cold 5% trichloroacetic acid, and centrifuged 
at 1000 g for 10 min. The supernatants were extracted with 
3 volumes of water-saturated diethyl ether. After drying, 
the extracts were stored at -70°C until the cAMP assay.
Statistical analysis
All variables are presented as mean ± standard deviation. 
Differences in the contractile effect of d- and l-limonene 
were analyzed using the unpaired t test. Differences in 
the contractile effect of NA in the MGO experiments were 
analyzed using one-way ANOVA tests with the Dunnett’s 
multiple comparison test. Concentration-response curves 
were fitted, areas under the curve (AUC) determined, and 
maximal inhibitory effects (Emax) calculated with the Prism 
4.0 software (Graphpad Software Inc. San Diego, CA, USA). 
Differences between the control cAMP and other groups 
were analyzed using one-way ANOVA tests with the Dun-
nett’s multiple comparison test. The value of P < 0.050 was 
considered statistically significant.
ReSUlTS
effects of limonene on pregnant rat myometrium
Both D- and l-limonene caused myometrial contrac-
tion in a dose-dependent manner (Figure 1). L-li-
monene caused significantly stronger myometrial con-
traction (Emax = 104.1% ± 35.33%) (P = 0.035) than 
d- limonene (Emax = 75.3% ± 34.4%). Pre-treatment with 
nifedipine (10−8 M) (Figure 2A) significantly decreased 
the myometrial contracting effect of both d-limonene 
FiGURe 1. The effect of d- and d-limonene (10−13-10−8 M) on 
uterine contraction. Change in contraction intensity was 
calculated using the areas under the curve and expressed in 
percent ± standard deviation (unpaired t test, P = 0.041).
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(Emax = 9.9% ± 37.4%) (P = 0.009) and l-limonene (Figure 
2B) (Emax = 23.21% ± 28.3%) (P < 0.001).
Pre-treatment with TEA (10−3 M) (Figure 3A) significant-
ly decreased the myometrial contracting effect of both 
d-limonene (Emax = 31.6% ± 21.88%) and l-limonene 
(Emax = 54.6% ± 31.23%) (P < 0.049), while paxilline 
(10−5 M) reversed this action and caused muscle relax-
ation (Emax = -33.5% ± 27.02% for d-limonene, P < 0.001), 
(Emax = -33.2% ± 26.84% for l-limonene, P < 0.001).
Pre-treatment with theophylline (10−5M) significant-
ly decreased the myometrial contracting effect of d-li-
monene (Emax = 75.34% ± 51.28%) (P = 0.048) (Figure 4A), 
but did not alter the contracting effect of l-limonene 
(Emax = 94.6% ± 25.95%) (Figure 4B).
Measurement of preventive effect of limonene against 
MGo-induced oxidative stress
MGO treatment (3 × 10−2 M) significantly reduced the NA-
evoked smooth muscle contraction in vitro (P = 0.003). 
While d- limonene (10−6 M) was ineffective (Figure 5A), l-
limonene (10−6 M) significantly decreased the effect of 
MGO (P = 0.043) (Figure 5B). Both NAC and tocopherol sig-
nificantly decreased the effect of MGO on myometrium 
(P = 0.003) (Figure 6).
FiGURe 2. The effect of d-limonene (A) and l-limonene (both 
10−13-10−8 M) (B) on uterine contraction after nifedipine (10−8 
M) pre-treatment. Change in contraction was calculated using 
the areas under the curve and expressed in percent ± standard 
deviation (unpaired t test, P = 0.048).
FiGURe 3. The effect tof d-limonene (A) and l-limonene (both 
10−13-10−8 M) (B) on uterine contraction after tetraethyl-ammo-
nium (TeA) (10−3 M) or paxilline (10−5 M) pre-treatment. Change 
in contraction was calculated using the areas under the curve 
and expressed in percent ± standard deviation (unpaired t test, 
P = 0.050).
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cAMP experiments
In two different concentrations (10−13, 10−9 M) d-limonene 
decreased cAMP synthesis (Figure 7A). Paxilline (10−5 M) 
pre-treatment prevented the effect of d-limonene on 
cAMP production, however it did not cause any significant 
changes compared to controls (IBMX, forskolin, NA).
L-limonene significantly decreased the cAMP level at the 
concentration of 10−9 M, but at 10−13 M concentration ex-
hibited no significant effects compared to the control. 
Paxilline (10−5 M) pre-treatment prevented the effect of 
l-limonene on cAMP production, but did not change the 
cAMP level compared to controls (Figure 7B).
diSCUSSion
Our study showed that both d- and l-limonene caused 
myometrial contraction in a dose-dependent manner. The 
myometrial effect of limonene was decreased by pre-treat-
ment with nifedipine and TEA, while in the presence of 
paxilline, limonene did not cause myometrial contraction. 
These findings suggest that increased intracellular calcium 
FiGURe 4. The effect of d-limonene (A) and l-limonene (both 
10−13-10−8 M) (B) on uterine contraction after theophylline (10−5 
M) pre-treatment. Change in contraction was calculated using 
the areas under the curve and expressed in percent ± standard 
deviation (unpaired t test, P = 0.048).
FiGURe 5. The effect of d-limonene (10−6 M) (A) and l-limonene 
(10−6 M) (B) on the noradrenaline-evoked (control) uterine 
contractions in the presence of methylglyoxal (3 × 10−2 M) and 
β-adrenoreceptor antagonist propranolol (10−5 M) (dunnett’s 
multiple comparison test, P = 0.043).
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pathways and BKCa channels can be involved in the action 
mechanism of limonene.
One study (28) showed that limonene was an adenosine 
A2A receptor agonist. A2A receptor agonists bind to G-cou-
pled receptors and stimulate protein kinase A and induce 
formation of inositol 1,4,5-triphosphate, which stimulates 
opening of endoplasmic reticulum Ca2+ channels, and re-
sults in increased intracellular Ca2+ levels (29). We investi-
gated the effect of limonene on adenosine receptors in 
the presence of theophylline. Theophylline pre-treatment 
significantly decreased the myometrial contracting effect 
of d-limonene, but did not affect the myometrial contract-
ing effect of l-limonene. There are two main sources of 
intracellular Ca2+ level increase in the myometrium: volt-
age-gated L-type Ca2+ channel influx and sarcoplasmic re-
ticulum (SR) release (30). The L-type Ca2+ channel activity 
is also regulated by the SR (31), and its depletion activates 
the L-type Ca2+ channel. The results of the current study 
are in accordance with these findings and suggest that 
d-limonene stimulates A2A receptors, which causes open-
ing of L-type Ca2+ channels and hence causes myometrial 
contraction, while l-limonene causes myometrial smooth 
muscle contraction independently of A2A receptors.
To find an explanation for this, we measured the uterine 
cAMP accumulation since cAMP levels are crucial in the 
control of smooth muscle contraction and relaxation. 
Phosphodiesterase inhibitor IBMX was used to block the 
degradation of the generated intracellular cAMP, while for-
skolin was used to enhance the activity of adenyl cyclase 
(18). D- and l-limonene decreased the cAMP level, which 
contributed to their myometrial contracting effect. After 
paxilline pre-treatment, limonene did not alter the cAMP 
level compared to the control. BKCa channels are important 
in maintaining myometrial quiescence (32). They are acti-
vated by increased intracellular Ca2+ levels and counteract 
depolarizing effects of Ca2+ by deactivating voltage-gated 
calcium channels or through increased transport activity 
of Na+/Ca2+ exchangers (33). It is plausible that paxilline-
induced BKCa channel blocking inhibits intracellular calci-
um sparks, which may explain why d- and l-limonene had 
FiGURe 6. The effect of n-acetylcysteine (10−7 M) and tocoph-
erol (10−7 M) on the noradrenaline-evoked (control) uterine 
contractions in the presence of methylglyoxal (3 × 10−2 M) and 
β-adrenoreceptor antagonist propranolol (10−5 M) (dunnett’s 
multiple comparison test, P = 0.025).
FiGURe 7. The effect of d-limonene (A) and l-limonene (B) on 
the myometrial cyclic adenosine monophosphate (pmol/mg 
tissue ± standard deviation) in the presence of isobuthylm-
ethylxantine (10−3 M), forskolin (10−5 M) (control), and paxilline 
(10−5 M) (AnoVA followed by dunnett’s multiple comparison 
test, P < 0.001).
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weaker contracting effect on the myometrium. Addition-
ally, TEA slightly decreased the myometrial contracting ef-
fect of limonene, which corresponds to the fact that TEA 
just partially blocks the BKCa channels (34). The increased 
intracellular Ca2+ level directly inhibits the cAMP system 
(35), therefore, if the BKCa channel is blocked and there is 
weaker calcium flow, cAMP level can return to normal.
Results of several studies suggest the terpenoids may have 
antioxidant effects (13,36). Therefore, we investigated the 
protective effect of limonene on oxidative damage of uter-
ine contractility in pregnancy. MGO is a reactive alpha-di-
carbonyl compound synthesized in various biochemical 
processes in most mammalian cells, including vascular en-
dothelial cells and smooth muscles (37). It increases super-
oxide production and inhibits NA-induced smooth muscle 
contraction in rat isolated carotid artery, which can be pre-
vented by NAC pre-treatment (19). First we investigated if 
the same model can be applied to investigating myometrial 
smooth muscle contraction and relaxation. MGO decreased 
the NA-induced myometrial smooth muscle contraction, 
which was prevented by NAC and tocopherol pre-treat-
ment. L-limonene significantly decreased the inhibitory ef-
fect of MGO, although this effect was weaker than that of 
NAC and tocopherol. This study provides the first evidence 
that limonene in low concentrations causes myometrial 
smooth muscle contraction. It activates A2A receptors and 
mediates voltage-gated Ca2+ channel opening, which is the 
major mechanism of Ca2+ for myometrial smooth muscle 
contraction. We also demonstrated for the first time that 
MGO treatment has inhibitory effects on the NA-evoked 
myometrial smooth muscle contraction, which could be 
prevented by l-limonene, NAC, and tocopherol pre-treat-
ment. Therefore, l-limonene has a contraction maintaining 
effect on the pregnant uterus. Although d-limonene is the 
dominant enantiomer in most plants, both enantiomers are 
used as specific blends in different consumer products (38).
A limitation of our study is that we did not carry out con-
tractility studies on human myometrium, therefore we can 
conclude that the same effect can be obtained in humans. 
However, our present findings suggest that limonene-con-
taining products may increase uterine contractions during 
pregnancy.
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